Warning letters, 483s, Recalls, Import Alerts, Audit observations
The USFDA Warning letter to K. C. Pharmaceuticals issued in August 2023, following inspection at
Medgel, India was issued a Warning letter by USFDA in July 2023. Deficiencies include inadequate
Medgel, India was issued a Warning letter by USFDA in July 2023. Deficiencies include inadequate
Medgel, India was issued a Warning letter by USFDA in July 2023. Deficiencies include inadequate
Several manufacturers of OTC drug products including mouthwash, toothpaste, topical analgesics, Sunscreen products, Hand Sanitizers
Related Links Warning letter Intas Warning letter Centaur Warning letter Medgel Warning letter Baxter Intas
Lupin has received correspondence from the US FDA that Lupin has addressed the concerns raised
Centaur Pharmaceuticals, India issued Warning letter by USFDA. The Warning letter dated 5 June 2023
Aurobindo Unit 1 (FEI 3004021253) was inspected by USFDA investigator Rita K Kabaso from August
Potential contamination of drug products with Diethylene Glycol(DEG), Ethylene Glycol(EG) has severe consequences including fatality
